Financial Data and Key Metrics Changes - CarVicti net trade sales reached approximately $439 million, representing a 136% increase year over year and a 19% increase from the first quarter [7][17] - Total revenues were RMB 255 million, driven by collaboration revenue growth of 136% year over year [30] - The company reported a net loss of RMB 10 million but achieved RMB 10 million in adjusted net income after excluding non-core items [30] - Operating loss improved from RMB 41 million in the same period last year to RMB 22 million [30] - Gross margin on net product sales was 57% [30] Business Line Data and Key Metrics Changes - CarVicti's U.S. net trade sales were $358 million, growing 114% year over year and 13% quarter over quarter [18] - Outside the U.S., sales were $81 million, which is four times the amount from the same period a year ago, representing a 59% increase quarter over quarter [19] Market Data and Key Metrics Changes - Over 60% of CarVicti utilization is now in earlier line settings [8] - The company has treated over 7,500 patients with CarVicti, marking it as the strongest CAR T launch to date [7][16] Company Strategy and Development Direction - The company aims to achieve operational breakeven for CarVicti by 2025 and company-wide profitability in 2026, excluding unrealized foreign exchange gains or losses [8][30] - The company is focused on solidifying its leadership in cell therapy and expanding into new indications such as solid tumor programs [14][15] - A new research facility is being built in Philadelphia to focus on in vivo delivery, enhancing innovation capabilities [15] Management's Comments on Operating Environment and Future Outlook - Management expressed optimism about the FDA's decision to remove risk evaluation and mitigation strategies for approved CAR T therapies, which is expected to improve patient experience and access [8] - The company anticipates continued strong performance for CarVicti, driven by recent long-term survival data presented at ASCO [21][28] Other Important Information - The company has a cash position of approximately $1 billion, allowing for continued investment in core differentiators in cell therapy [16][32] - Manufacturing success rate remains at 97%, which is believed to be the highest in the CAR T industry [20] Q&A Session Summary Question: Update on interim readouts from CARDISUDE V and VI - Management is monitoring events closely and is in discussions with the FDA about using MRD as a dual primary endpoint [37][38] Question: Community oncology efforts and Virginia Oncology Associates - Virginia Oncology Associates is a key milestone for community adoption, having previously administered CAR T therapies and is part of the McKesson network [39] Question: Revenue contribution from community expansion efforts - Approximately 70% of patients come from the community setting, with over half of patients administered in outpatient settings [42][43] Question: Breakdown of treated patients in early line settings - Nearly 60% of orders are from the second through fourth line population, which is expected to grow significantly [48] Question: Impact of recent efficacy data from a competitor - Management emphasized that CarVicti is best in class with demonstrated overall survival benefits, differentiating it from competitors [63] Question: Future demand and supply dynamics - The company plans to drive both supply and demand simultaneously, with increasing contributions expected from Europe [83][85] Question: Novartis commercial supply ramp-up - Novartis is expected to reach full capacity by the end of the year, contributing to growth [107] Question: Impact of recent tariff changes - The company believes any potential exposure to tariffs will not be material based on current evaluations [103]

BioHarvest Sciences (BHST) Q2 2025 Earnings Call August 11, 2025 08:00 AM ET Speaker0Greetings, and welcome to the BioHarvest Sciences Second Quarter twenty twenty five Corporate Update Conference Call. At this time, all participants are in listen only mode. A question and answer session will follow the formal presentation. As a reminder, this conference is being recorded. Before we begin the formal presentation, I'd like to remind everyone that statements made on today's call and webcast, including those r ...

Financial Data and Key Metrics Changes - The company reported total revenue of approximately $510 million for the quarter, with adjusted EBITDA of $280 million, reflecting a significant year-over-year increase in EBITDA and cash flow, nearly doubling from the previous year [5][19] - Adjusted EBITDA for 2025 reached $418 million, with a second-quarter adjusted EBITDA margin of 63% [19] - Free cash flow for the quarter was $88 million, impacted by approximately $25 million in non-recurring transaction-related costs, while net debt stood at approximately $2.6 billion, showing a 10% improvement in overall leverage [20][21] Business Line Data and Key Metrics Changes - Daily production exit rate for June was approximately 1.14 Bcf per day, with quarterly production averaging over 1.15 Bcf per day, with 65% of produced volumes generated in the expanded Central region [19] - The company has increased its total proved reserves by 65% since year-end 2024, indicating strong asset base resilience [10] Market Data and Key Metrics Changes - The company noted improvements in in-basin natural gas differentials, which are expected to benefit from rising natural gas demand driven by data center developments in the Appalachian region [15][16] - The company is positioned to benefit from the growing demand for natural gas, particularly for power generation and off-grid sources, as indicated by significant investments in the region [61][62] Company Strategy and Development Direction - The company focuses on a disciplined capital allocation strategy centered around debt reduction, returning capital to shareholders, and growing its portfolio through strategic acquisitions [8][10] - The partnership with Carlyle is aimed at supporting accretive acquisitions, with a potential to fund up to $2 billion worth of acquisitions without raising new equity capital [12][13] - The company aims to optimize cash flow from low decline energy assets while enhancing growth through strategic acquisitions [5][11] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in delivering strong operational and financial results despite increased market volatility due to external factors [7] - The company anticipates continued growth opportunities in the coming years, particularly in the context of maturing assets and M&A activity [12][13] - Management highlighted the undervaluation of shares and the potential for a re-rate based on strong fundamentals and consistent performance [31][32] Other Important Information - The company has returned approximately $2 billion in shareholder returns and debt repayments since its IPO in 2017, demonstrating a strong commitment to creating shareholder value [10][30] - The company has a healthy liquidity position of approximately $420 million, providing flexibility to navigate volatile markets [21] Q&A Session Summary Question: How does the Oklahoma JV fit into the core portfolio? - Management indicated that the Oklahoma JV is a steady program with potential for expansion into other basins, emphasizing the strong returns and ongoing development opportunities [40][42] Question: How are discussions going with Carlyle regarding dual procurement? - Management confirmed ongoing evaluations of opportunities with Carlyle, emphasizing the importance of disciplined acquisition strategies and the favorable environment for acquisitions due to lower commodity prices [44][45] Question: Can you provide information on land sales expectations? - Management noted higher realizations on undeveloped acreage sales and expressed confidence in additional sales opportunities, particularly in the Permian region [50][54] Question: What is the status of well retirements and third-party business? - Management reported a consistent pace of well plugging activities, with approximately 400 wells expected to be plugged this year, while third-party revenue remains steady [55][57] Question: How does the company view the AI data center opportunity? - Management expressed enthusiasm about the growing demand for natural gas driven by data center developments, highlighting potential pricing benefits and smaller-scale power generation opportunities [61][62] Question: What is the updated synergy capture expectation? - Management raised the synergy capture expectation to approximately $60 million, up from initial estimates of $50 million, citing successful integration efforts and operational efficiencies [64][66] Question: What are the footprint expansion opportunities post-Maverick acquisition? - Management highlighted ongoing portfolio optimization efforts across multiple basins, with confidence in identifying further opportunities for cost synergies and production enhancements [71][75]

Financial Data and Key Metrics Changes - Revenue for Q2 2025 was $20.5 million, down from $23.1 million in the prior year, but above guidance of $18 million to $20 million due to higher shipments to China [6] - Gross margin decreased to 56.4% from 57.2% in Q2 2024, but was at the high end of guidance [6] - Adjusted operating income improved to $1 million from $800,000 in Q2 2024, and adjusted EBITDA increased to $1.5 million from $1.3 million [7][12] - Year-to-date cash flow from operations was strong at $5.7 million compared to $600,000 in the same period last year [13] Business Line Data and Key Metrics Changes - Revenue in The Americas declined 5.4% sequentially and 11.7% year-over-year, primarily due to budget clarity issues for academic institutions [8] - European revenue increased 9% sequentially, driven by stronger academic shipments, while year-over-year revenues were largely flat [10] - APAC revenue decreased over 25% year-over-year due to tariff-related issues, with orders and shipments halting in April but gradually returning to normal [11] Market Data and Key Metrics Changes - The company’s China business accounted for about 10% of revenue, which nearly went to zero in April but has since returned to a more normal run rate [32] - NIH funding delays are extending academic purchasing cycles, but budgets remain in place, with expectations for improvement into 2026 [19] Company Strategy and Development Direction - The company aims to maintain financial discipline, accelerate product adoption, and strengthen its capital structure through refinancing [17][18] - New product pipeline includes the SOHO telemetry platform and the MeSH MEA organoid platform, which are expected to drive future growth [20][21] Management's Comments on Operating Environment and Future Outlook - Management expressed optimism about the second half of the year, believing that the worst of tariff uncertainties is behind them [19] - The company is focused on stabilizing its core business and restructuring its balance sheet to build sustainable sales and profitability [22] Other Important Information - Net debt decreased to $27.9 million from $32 million, reflecting improved operating cash flow and quarterly principal payments [14] - The company has negotiated amendments to its credit facility, providing additional time to refinance and pay down existing debt [15] Q&A Session Summary Question: What do you expect total debt to be by December 5? - The company expects debt to be around $33 million, continuing to pay down $1 million per quarter [26] Question: What are your thoughts on NIH funding and potential budget changes? - Management noted that academic purchasing cycles have been extended, but budgets remain in place, which could benefit the business if conditions improve in 2026 [30] Question: What is your current exposure to China and how did it perform in the quarter? - The China business is about 10% of revenue, which saw a significant decline in April but has returned to normal levels [32]

Financial Data and Key Metrics Changes - Total revenue for 2025 was $37.9 million, down from $42.8 million in 2024, primarily due to $6 million of non-recurring license-related revenue recognized in 2024 [38] - U.S. XPOVIO net product revenue for 2025 was $29.7 million, compared to $28 million in 2024, reflecting a 6% increase [32][39] - The gross to net provisions for XPOVIO in Q2 2025 were 26.8%, down from 45% in Q1 2025 and 29.3% in 2024 [39] - The company reported a net loss of $37.3 million or $4.32 per share on a GAAP basis, which includes $11.2 million in interest expense [42] Business Line Data and Key Metrics Changes - XPOVIO net product revenue was consistent, with the community setting driving approximately 60% of total U.S. sales [32] - The company expects net product revenue for the full year 2025 to be in the range of $110 million to $120 million [39] Market Data and Key Metrics Changes - The peak revenue potential for selinexor in myelofibrosis is estimated to be up to $1 billion annually in the U.S. alone [10][35] - Royalty revenue increased by 28% to $1.6 million in 2025 compared to 2024, reflecting increased global demand for XPOVIO and NexpoVIO [34] Company Strategy and Development Direction - The company is focused on enhancing liquidity and maximizing value while preparing for potential launches in myelofibrosis and endometrial cancer [6][45] - The company aims to redefine the standard of care for myelofibrosis with the combination of selinexor and ruxolitinib, pending positive data from ongoing trials [9][45] Management's Comments on Operating Environment and Future Outlook - Management acknowledged financial constraints with a near-term debt maturity in October and is actively engaged with lenders to enhance liquidity [6] - The company remains optimistic about the potential for selinexor plus ruxolitinib to improve treatment outcomes for myelofibrosis patients [9][45] Other Important Information - The company announced a 20% reduction in workforce to optimize costs, expecting to lower annual spend by approximately $13 million in 2026 [43] - The company exited 2025 with cash and equivalents of $52 million, down from $109.1 million at the end of 2024 [43] Q&A Session Summary Question: Concerns about myelofibrosis readout and preparation for multiple data readouts - Management expressed excitement about the upcoming readouts and confidence in leveraging existing commercial capabilities to prepare for potential launches in myelofibrosis and endometrial cancer [50][51] Question: Impact of higher baseline TSS on trial results - Management indicated that higher baseline TSS could lead to more meaningful outcomes in the trial, with ongoing monitoring of patient characteristics [60][61] Question: Reasons for lower rates of grade three anemia with combination therapy - Management attributed lower rates of grade three anemia to potential disease modification effects of selinexor, including reductions in key cytokines [62][63] Question: Confidence in blinded safety data holding once unblinded - Management expressed optimism about the safety profile observed in blinded data, noting consistency with historical ruxolitinib safety data [71][72]

Financial Data and Key Metrics Changes - The company reported revenue of $415 million for H1 2025, representing a year-on-year growth of 4% [39] - EBITDA for the same period was $185 million, reflecting a significant increase of 1512% year-on-year [38] - Total customer deposits more than doubled to $3.1 billion, with an average deposit per active customer reaching approximately $17,000 [24][38] - The company ended the first half with cash balances of approximately $938 million and no debt [6][41] Business Line Data and Key Metrics Changes - Non-OTC revenues accounted for approximately 13% of the group's total revenue in 2025, up from just 1% when the futures business was acquired in 2021 [23] - The futures business saw customer segregated funds grow to approximately $850 million, a 140% increase from the previous year [25] - 66% of OTC revenue was derived from customers who have been trading with the company for over three years, indicating strong customer retention [8] Market Data and Key Metrics Changes - The company expanded its geographic reach with new offerings in Japan and the conditional acquisition of MetaEquities in India [5] - The UAE and the US were highlighted as key markets driving growth [5] Company Strategy and Development Direction - The company aims to deepen customer engagement and enhance retention through investments in technology and customer service [9] - The strategic roadmap focuses on diversification into non-OTC products and expanding operations in new markets [49] - The company is committed to being carbon negative by 2030 and has moved to a more energy-efficient headquarters [15] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the structural growth opportunities ahead and the positive momentum in the business [4] - The company is well-positioned to leverage its proprietary technology and regulatory licenses to drive future growth [20][47] Other Important Information - The company announced shareholder returns of $365 million for the year to date, equivalent to 11% of its market capitalization as of June 30, 2025 [6] - Plus500 has been recognized as the best-performing share in the FTSE All Share Index over the last twelve years [7] Q&A Session Summary Question: Impact of regulatory changes in India on MetaEquities - Management views the new regulatory changes in India as positive, as they support a more structured and regulated market environment [54][55] Question: Growth in non-OTC customer deposits - The company has exceeded its initial targets for non-OTC customer deposits, but management emphasizes the importance of balancing growth across both OTC and non-OTC segments [56][57] Question: Dynamics behind growth in customer deposits - Growth in customer deposits is driven by onboarding new institutional customers and introducing brokers, which has led to increased deposits from their customer bases [61][62] Question: Improvements in customer retention - The company has focused on enhancing its technology stack and integrating AI and big data capabilities to improve customer retention and reduce churn rates [64] Question: Future revenue acceleration from non-OTC products - Management anticipates continued growth in revenues from non-OTC products as the company invests in new fundamentals and expands its offerings [67] Question: Marketing efficiency improvements - The company has optimized its marketing strategies, leading to lower customer acquisition costs while increasing the quality of earnings and customer longevity [72]

Financial Data and Key Metrics Changes - The company reported revenue of $415 million for the first half of 2025, representing a year-on-year growth of 4% [40] - EBITDA grew significantly by 1512% year-on-year, reaching $185 million [39] - Total customer deposits more than doubled to $3.1 billion, with an average deposit per active customer increasing to approximately $17,000 [25][39] - The company ended the period with cash balances of approximately $938 million and no debt, indicating a strong financial position [42] Business Line Data and Key Metrics Changes - Non-OTC revenues accounted for approximately 13% of the group's total revenue in 2025, up from just 1% when the futures business was acquired in 2021 [24] - The futures business saw customer segregated funds grow to approximately $850 million, a 140% increase from the previous year [26] - 66% of OTC revenue was derived from customers who have been trading with the company for over three years, highlighting customer retention [9] Market Data and Key Metrics Changes - The company expanded its operations into new markets, including the UAE and Canada, and secured a new license in Japan [10][20] - The acquisition of MetaEquities in India is expected to enhance the company's presence in a significant market [18][14] - The company operates in over 60 countries, serving approximately 32 million registered customers [21] Company Strategy and Development Direction - The company aims to deepen customer engagement and enhance retention through investments in technology and customer service [10] - A strategic roadmap has been established to focus on growth, innovation, and diversification into non-OTC products [48] - The company is committed to maintaining its competitive advantage through proprietary technology and expanding its product offerings [30][10] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the structural growth opportunities ahead and the positive momentum in the business [4] - The company views regulatory changes in India as positive for long-term growth and market stability [54] - There is a focus on balancing growth between non-OTC and OTC segments to ensure robust returns [57] Other Important Information - The company has returned approximately $365 million to shareholders year-to-date, equivalent to 11% of its market capitalization [6] - Plus500 has been recognized as the best-performing share in the FTSE All Share Index over the last twelve years [7] - The company is committed to being carbon negative by 2030 and has moved to a more energy-efficient headquarters [15] Q&A Session Summary Question: What are the implications of regulatory changes in India for MetaEquities? - Management views the new regulatory changes as positive, as they support a more structured and regulated market, which can attract new customers [55] Question: What is driving the growth in non-OTC customer deposits? - The growth is primarily driven by recruiting introducing brokers, which brings in their customers, thus increasing deposits [63] Question: What strategies have been implemented to improve customer retention? - The company has focused on enhancing its technology stack and integrating AI and big data capabilities to improve customer retention and reduce churn rates [65] Question: When can we expect revenue from non-OTC products to accelerate? - Management anticipates continued growth in revenues as investments in new products and geographies yield results [68] Question: What changes have been made to improve marketing efficiency? - The company has optimized its marketing processes, leading to lower customer acquisition costs while increasing the quality of earnings and customer longevity [71]

Financial Data and Key Metrics Changes - Operating revenue increased by 13.5% year over year, reaching KRW 7,427.4 billion [6] - Operating profit rose by 105.4% year over year, amounting to KRW 1,014.8 billion, supported by balanced growth in the telco business and one-time gains from real estate sales [6] - Net income increased by 78.6% year over year to KRW 733.3 billion, driven by higher operating profit [6] - EBITDA grew by 36.3% year over year, reporting KRW 1,990.7 billion [6] - Operating expenses increased by 5.9% year over year, totaling KRW 6,412.6 billion [7] Business Line Data and Key Metrics Changes - Wireless revenue increased by 0.9% year on year, reporting KRW 1,781.7 billion, with 5G subscribers accounting for 79.5% of total handset subscribers [8] - Fixed line broadband revenue grew by 2.1% year over year, reaching KRW 631.4 billion, driven by Giga Internet subscriber growth [9] - B2B service revenue posted a 4.5% year on year growth, supported by telecom and AI/IT services [10] - AIIT business revenues saw a significant increase of 13.8% year over year [10] - KT Cloud revenue grew by 23% year on year, driven by increased data center usage [11] Market Data and Key Metrics Changes - The company noted that the 5G penetration rate is above 80%, indicating a mature market [20] - The handset replacement cycle has lengthened, affecting market dynamics [20] Company Strategy and Development Direction - KT is focused on transforming into an AICT company and enhancing corporate value through strategic initiatives [3][12] - The company plans to complete a share buyback of KRW 250 billion and has increased its dividend by 20% year over year [4] - KT is actively pursuing large-scale AI projects and collaborations, including partnerships with Microsoft and Palantir [16][17] - The company aims to leverage AI capabilities to enhance operational efficiency and service offerings [18] Management Comments on Operating Environment and Future Outlook - Management expressed confidence in sustaining solid service revenue growth into the second half of the year, despite a significant one-time gain in Q2 [24] - There are concerns about potential increases in commissions and selling-related expenses, but these are linked to earnings performance [25] - The company is committed to maintaining a shareholder-friendly dividend policy and plans additional share buybacks [27] Other Important Information - KT plans to invest KRW 1 trillion in information security over five years to enhance customer safety [5] - The company is developing a Korean-tailored AI model powered by ChatGPT for its services [5] Q&A Session Summary Question: AI business direction and M&P market outlook - Management highlighted three strategies for AI: partnerships with global tech firms, a multi-model strategy, and leveraging AI for operational efficiency [16][17] - Regarding the M&P market, management noted that while competition may heat up with new handset launches, it is not expected to be long-lasting due to high 5G penetration and longer handset replacement cycles [20] Question: Outlook for the second half and updates on the value plan - Management expects to continue good momentum into the second half, driven by solid service revenue and improved cost management [24] - The dividend decision is based on 50% of adjusted net profit, and management is confident in meeting market expectations for shareholder returns [26][27]

Financial Data and Key Metrics Changes - Operating revenue increased by 13.5% year over year, reaching KRW 7,427.4 billion [6] - Operating profit rose by 105.4% year over year, amounting to KRW 1,014.8 billion, supported by balanced growth in the telco business and one-time gains from real estate sales [6] - Net income increased by 78.6% year over year to KRW 733.3 billion, driven by higher operating profit [6] - EBITDA grew by 36.3% year over year, reporting KRW 1,990.7 billion [6] - Operating expenses rose by 5.9% year over year, totaling KRW 6,412.6 billion [7] Business Line Data and Key Metrics Changes - Wireless revenue increased by 0.9% year on year, reporting KRW 1,781.7 billion, with 79.5% of total handset subscribers being 5G subscribers [8] - Fixed line broadband revenue grew by 2.1% year over year, reaching KRW 631.4 billion, driven by Giga Internet subscriber growth [9] - B2B service revenue posted a 4.5% year over year growth, supported by telecom and AI/IT services [11] - AIIT business revenues saw a significant increase of 13.8% year over year [11] - KT Cloud revenue grew by 23% year over year, driven by increased data center usage [12] Market Data and Key Metrics Changes - The company noted that the 5G penetration rate is above 80%, indicating a mature market [21] - The company observed no overheating of competition in the market following the launch of new flagship handsets, although future competition may arise with new iPhone releases [20] Company Strategy and Development Direction - The company is focused on transforming into an AICT company and enhancing corporate value through strategic initiatives [4][13] - A multi-model strategy is being implemented, including partnerships with global tech firms like Microsoft and Palantir to enhance competitiveness in AI services [17] - The company plans to invest KRW 1 trillion in information security over five years to improve customer safety in telecom services [5] Management Comments on Operating Environment and Future Outlook - Management expressed confidence in sustaining solid service revenue growth into the second half of the year, despite a significant one-off gain from real estate in Q2 [25] - Concerns were raised about potential increases in commissions and selling-related expenses, but these are linked to earnings performance [26] - The company is committed to maintaining a shareholder-friendly dividend policy, with a declared dividend of KRW 600 per share, a 20% increase year over year [4][27] Other Important Information - The company plans to complete a share buyback of KRW 250 billion and has outlined a future buyback plan totaling KRW 750 billion over the next three years [4][28] Q&A Session Summary Question: Future direction of AI business and impact of handset subsidy repeal - Management highlighted three main strategies for AI: partnerships with global tech firms, a multi-model strategy for AI service development, and leveraging AI capabilities for operational efficiency [17][19] - Regarding the M and P market, management noted that while competition may heat up with new handset launches, it is not expected to be long-lasting due to high 5G penetration and longer handset replacement cycles [20][21] Question: Outlook for the second half of the year and updates on the value plan - Management expressed optimism for continued strong performance in the second half, driven by solid service revenue and improved cost management [25] - The company confirmed its commitment to a shareholder-friendly dividend policy and plans for additional share buybacks as part of its value enhancement program [27][28]

Financial Data and Key Metrics Changes - The company delivered FFO and DPS of 20.7¢ per security, slightly above guidance of 20.6¢, with like-for-like income growth of 2.9% and occupancy reaching 99.9% [4][7][8] - Gearing stands at 29.4%, positioned at the lower end of the target range, expected to increase with capital deployment into growth opportunities [5][9] - NTA per security grew by 8¢ or 2.2% to $3.64, supported by underlying rental growth and cap rate compression [8][10] Business Line Data and Key Metrics Changes - The portfolio consists of over 90 assets valued at over $700 million, with a significant focus on metro and highway locations [2][3] - The company executed $38.8 million in divestments in the first half, enhancing portfolio quality and providing balance sheet capacity for future growth [4][12] Market Data and Key Metrics Changes - Property valuations increased by 2.3%, driven by rental growth and cap rate compression of eight basis points [10] - The portfolio capitalization rate is 6.32%, supported by strength in the underlying transaction market [10] Company Strategy and Development Direction - The company is focused on developing the Glasshouse Mountains project, which will enhance overall portfolio quality and increase strategic weighting to highway assets [11][12] - Future growth initiatives include progressing the redevelopment of Glasshouse Mountain southbound and securing other growth opportunities [13] Management's Comments on Operating Environment and Future Outlook - Management noted a slowdown in momentum leading up to the federal election, but a strong increase in volumes post-election [11] - For FY '26, the company expects to deliver FFO and distributions per security of 20.9¢, reflecting year-on-year growth of 1.2% [13] Other Important Information - The company maintains a carbon-neutral position across controlled assets and engages with tenants to support their ESG objectives [6] - Environmental initiatives are integral to development plans, including EV charging bays and renewable energy sources [7] Q&A Session Summary Question: Can you walk us through the bridge in FY '26 regarding key moving parts and drivers? - Management indicated that like-for-like NOI growth will be similar, offset by a moderate increase in the cost of debt and dilution from asset sales [16] Question: Are you assuming any more capital deployment during the period? - Guidance does not assume capital deployment beyond the Glasshouse Mountains northbound project [17] Question: What is the focus on the pipeline for restocking? - The focus is on convenience retail hubs and highway sites with truck stop facilities, with ongoing discussions with developers [18][19] Question: How much are you willing to spend on new projects? - The company has a buying capacity of approximately $50 to $60 million while remaining within the target gearing range [20] Question: What are the key metrics for the development project? - Expected development IRR is around 20%, with a long-term hold IRR of about 10% [22]